{"transactions":[{"id":1484020,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T20:51:43.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":false,"shares":5300,"price":57.06,"value":302418.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022."}],"balance_after":0,"derivative":{"exercise_price":57.06,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001579587-24-000013","document":"wk-form4_1718139096.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000013/wk-form4_1718139096.xml","form_type":"4"}},{"id":1484019,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T20:51:43.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":false,"shares":7250,"price":49.51,"value":358947.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":49.51,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001579587-24-000013","document":"wk-form4_1718139096.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000013/wk-form4_1718139096.xml","form_type":"4"}},{"id":1484018,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-06-11T20:51:43.000Z","date":"2024-06-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":11087,"price":67.7,"value":750589.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price."}],"balance_after":117829,"source":{"system":"sec-edgar","filing":"0001579587-24-000013","document":"wk-form4_1718139096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000013/wk-form4_1718139096.xml","form_type":"4"}},{"id":1484017,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-06-11T20:51:43.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":true,"shares":5300,"price":57.06,"value":302418.0,"ownership":{"direct":true},"balance_after":128916,"source":{"system":"sec-edgar","filing":"0001579587-24-000013","document":"wk-form4_1718139096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000013/wk-form4_1718139096.xml","form_type":"4"}},{"id":1484016,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-06-11T20:51:43.000Z","date":"2024-06-07","kind":"exercise","planned":false,"acquired":true,"shares":7250,"price":49.51,"value":358947.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares."}],"balance_after":123616,"source":{"system":"sec-edgar","filing":"0001579587-24-000013","document":"wk-form4_1718139096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000013/wk-form4_1718139096.xml","form_type":"4"}},{"id":1543341,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-04-12T01:13:13.000Z","date":"2024-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2799,"price":66.96,"value":187421.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported."}],"balance_after":116006,"source":{"system":"sec-edgar","filing":"0001579587-24-000011","document":"wk-form4_1712884382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000011/wk-form4_1712884382.xml","form_type":"4"}},{"id":1562325,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-03-25T20:14:31.000Z","date":"2024-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3653,"price":69.58,"value":254175.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported."}],"balance_after":118805,"source":{"system":"sec-edgar","filing":"0001579587-24-000009","document":"wk-form4_1711397661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000009/wk-form4_1711397661.xml","form_type":"4"}},{"id":1589868,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-03-08T02:42:07.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2034,"price":66.71,"value":135688.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,644 shares of restricted stock, the grant of which was previously reported."}],"balance_after":122458,"source":{"system":"sec-edgar","filing":"0001579587-24-000006","document":"wk-form4_1709865716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000006/wk-form4_1709865716.xml","form_type":"4"}},{"id":1589867,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-03-08T02:42:07.000Z","date":"2024-03-07","kind":"sale","planned":false,"acquired":false,"shares":24338,"price":66.37,"value":1615313.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $66.00 to $66.75. The price reported above reflects the weighted average sales price."}],"balance_after":124492,"source":{"system":"sec-edgar","filing":"0001579587-24-000006","document":"wk-form4_1709865716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000006/wk-form4_1709865716.xml","form_type":"4"}},{"id":1608052,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-03-01T22:09:18.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1058,"price":67.67,"value":71594.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,256 shares of restricted stock, the grant of which was previously reported."}],"balance_after":148830,"source":{"system":"sec-edgar","filing":"0001579587-24-000004","document":"wk-form4_1709330942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000004/wk-form4_1709330942.xml","form_type":"4"}},{"id":1639209,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-02-16T21:47:06.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":6710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":149888,"source":{"system":"sec-edgar","filing":"0001579587-24-000002","document":"wk-form4_1708120015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000002/wk-form4_1708120015.xml","form_type":"4"}},{"id":1639208,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2024-02-16T21:47:06.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":10066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024."}],"balance_after":143178,"source":{"system":"sec-edgar","filing":"0001579587-24-000002","document":"wk-form4_1708120015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958724000002/wk-form4_1708120015.xml","form_type":"4"}},{"id":1796807,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-25T20:17:55.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":33,"value":55011.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":33,"expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001579587-23-000005","document":"wk-form4_1692994664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958723000005/wk-form4_1692994664.xml","form_type":"4"}},{"id":1796806,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-25T20:17:55.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":40.59,"value":152212.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020."}],"balance_after":0,"derivative":{"exercise_price":40.59,"expiration_date":"2026-04-06","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001579587-23-000005","document":"wk-form4_1692994664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958723000005/wk-form4_1692994664.xml","form_type":"4"}},{"id":1796805,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-08-25T20:17:55.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":3932,"price":63,"value":247716.0,"ownership":{"direct":true},"balance_after":133112,"source":{"system":"sec-edgar","filing":"0001579587-23-000005","document":"wk-form4_1692994664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958723000005/wk-form4_1692994664.xml","form_type":"4"}},{"id":1796804,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-08-25T20:17:55.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":1667,"price":33,"value":55011.0,"ownership":{"direct":true},"balance_after":137044,"source":{"system":"sec-edgar","filing":"0001579587-23-000005","document":"wk-form4_1692994664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958723000005/wk-form4_1692994664.xml","form_type":"4"}},{"id":1796803,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-08-25T20:17:55.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":40.59,"value":152212.5,"ownership":{"direct":true},"balance_after":135377,"source":{"system":"sec-edgar","filing":"0001579587-23-000005","document":"wk-form4_1692994664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000157958723000005/wk-form4_1692994664.xml","form_type":"4"}},{"id":1921291,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-04-12T20:42:06.000Z","date":"2023-04-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2289,"price":38.5,"value":88126.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported."}],"balance_after":131627,"source":{"system":"sec-edgar","filing":"0001104659-23-044634","document":"tm2312564-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923044634/tm2312564-1_4seq1.xml","form_type":"4"}},{"id":1929763,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-04-05T00:06:06.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":8684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":133916,"source":{"system":"sec-edgar","filing":"0001104659-23-041737","document":"tm2311710-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041737/tm2311710-6_4seq1.xml","form_type":"4"}},{"id":1929762,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-04-05T00:06:06.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":13026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023."}],"balance_after":125232,"source":{"system":"sec-edgar","filing":"0001104659-23-041737","document":"tm2311710-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041737/tm2311710-6_4seq1.xml","form_type":"4"}},{"id":1935189,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-03-31T00:01:10.000Z","date":"2023-03-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":524,"price":38.62,"value":20236.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,712 shares of restricted stock, the grant of which was previously reported."}],"balance_after":112206,"source":{"system":"sec-edgar","filing":"0001104659-23-039340","document":"tm2311020-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923039340/tm2311020-2_4seq1.xml","form_type":"4"}},{"id":1938317,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-03-28T00:02:19.000Z","date":"2023-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":2452,"price":37.82,"value":92734.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported."}],"balance_after":112730,"source":{"system":"sec-edgar","filing":"0001104659-23-037251","document":"tm2310677-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923037251/tm2310677-3_4seq1.xml","form_type":"4"}},{"id":1961564,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-03-09T21:36:34.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":509,"price":44.23,"value":22513.07,"ownership":{"direct":true},"balance_after":115182,"source":{"system":"sec-edgar","filing":"0001104659-23-030618","document":"tm239061-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923030618/tm239061-1_4seq1.xml","form_type":"4"}},{"id":1961563,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2023-03-09T21:36:34.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":1951,"price":44.23,"value":86292.73,"ownership":{"direct":true},"balance_after":115691,"source":{"system":"sec-edgar","filing":"0001104659-23-030618","document":"tm239061-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923030618/tm239061-1_4seq1.xml","form_type":"4"}},{"id":2184722,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-08-17T01:01:19.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":5172,"price":37.7927,"value":195463.8444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $37.70 to $38.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":117642,"source":{"system":"sec-edgar","filing":"0001415889-22-008738","document":"form4-08162022_060804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922008738/form4-08162022_060804.xml","form_type":"4"}},{"id":2184721,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-08-17T01:01:19.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":12894,"price":37.0409,"value":477605.3646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $37.01 to $37.295. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":122814,"source":{"system":"sec-edgar","filing":"0001415889-22-008738","document":"form4-08162022_060804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922008738/form4-08162022_060804.xml","form_type":"4"}},{"id":2288148,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-04-29T22:35:22.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":6644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022."}],"balance_after":135708,"source":{"system":"sec-edgar","filing":"0001415889-22-004408","document":"form4-04292022_030410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922004408/form4-04292022_030410.xml","form_type":"4"}},{"id":2298816,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-04-12T21:13:21.000Z","date":"2022-04-10","kind":"tax_withholding","acquired":false,"shares":1878,"price":29.91,"value":56170.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported."}],"balance_after":129064,"source":{"system":"sec-edgar","filing":"0001415889-22-004022","document":"form4-04122022_020409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922004022/form4-04122022_020409.xml","form_type":"4"}},{"id":2300602,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-04-08T21:36:01.000Z","date":"2022-04-06","kind":"tax_withholding","acquired":false,"shares":337,"price":29.69,"value":10005.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, the grant of which was previously reported."}],"balance_after":130942,"source":{"system":"sec-edgar","filing":"0001415889-22-003968","document":"form4-04082022_020452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003968/form4-04082022_020452.xml","form_type":"4"}},{"id":2314397,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-03-30T20:13:08.000Z","date":"2022-03-28","kind":"tax_withholding","acquired":false,"shares":524,"price":28.17,"value":14761.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,712 shares of restricted stock, the grant of which was previously reported."}],"balance_after":131279,"source":{"system":"sec-edgar","filing":"0001415889-22-003472","document":"form4-03302022_010359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003472/form4-03302022_010359.xml","form_type":"4"}},{"id":2316968,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-03-29T00:49:22.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":19934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022."}],"balance_after":131803,"source":{"system":"sec-edgar","filing":"0001415889-22-003394","document":"form4-03282022_050305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003394/form4-03282022_050305.xml","form_type":"4"}},{"id":2318106,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2022-03-26T00:56:50.000Z","date":"2022-03-23","kind":"tax_withholding","acquired":false,"shares":2452,"price":27.03,"value":66277.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported."}],"balance_after":111869,"source":{"system":"sec-edgar","filing":"0001415889-22-003382","document":"form4-03252022_050339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003382/form4-03252022_050339.xml","form_type":"4"}},{"id":2750769,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2021-04-13T21:26:29.000Z","date":"2021-04-12","kind":"tax_withholding","acquired":false,"shares":1878,"price":31.86,"value":59833.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported."}],"balance_after":114321,"source":{"system":"sec-edgar","filing":"0001415889-21-001981","document":"form4-04132021_020416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001981/form4-04132021_020416.xml","form_type":"4"}},{"id":2754718,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2021-04-08T00:29:07.000Z","date":"2021-04-06","kind":"tax_withholding","acquired":false,"shares":337,"price":33.69,"value":11353.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, the grant of which was previously reported."}],"balance_after":116199,"source":{"system":"sec-edgar","filing":"0001415889-21-001946","document":"form4-04072021_050439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001946/form4-04072021_050439.xml","form_type":"4"}},{"id":2767004,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2021-04-01T00:57:41.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":278,"price":36.14,"value":10046.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 907 shares of restricted stock, the grant of which was previously reported."}],"balance_after":116536,"source":{"system":"sec-edgar","filing":"0001415889-21-001724","document":"form4-03312021_050326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001724/form4-03312021_050326.xml","form_type":"4"}},{"id":2767003,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2021-04-01T00:57:41.000Z","date":"2021-03-29","kind":"tax_withholding","acquired":false,"shares":524,"price":32.68,"value":17124.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,712 shares of restricted stock, the grant of which was previously reported."}],"balance_after":116814,"source":{"system":"sec-edgar","filing":"0001415889-21-001724","document":"form4-03312021_050326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001724/form4-03312021_050326.xml","form_type":"4"}},{"id":2772318,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OPS & PROD DEV"}}],"security":"Common Stock","published_at":"2021-03-25T20:45:52.000Z","date":"2021-03-23","kind":"grant","acquired":true,"shares":32041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 23, 2021."}],"balance_after":117338,"source":{"system":"sec-edgar","filing":"0001415889-21-001661","document":"form4-03252021_010339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001661/form4-03252021_010339.xml","form_type":"4"}},{"id":3177387,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2020-04-14T20:31:40.000Z","date":"2020-04-10","kind":"grant","acquired":true,"shares":24548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock vests in four equal annual installments on the first, second, third and fourth anniversaries of April 10, 2020."}],"balance_after":85297,"source":{"system":"sec-edgar","filing":"0001104659-20-046392","document":"tm2015775d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/tm2015775d1_form4.xml","form_type":"4"}},{"id":3179939,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2020-04-08T21:53:45.000Z","date":"2020-04-07","kind":"tax_withholding","acquired":false,"shares":144,"price":43.93,"value":6325.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 469 shares of restricted stock, which was previously reported."}],"balance_after":60749,"source":{"system":"sec-edgar","filing":"0001104659-20-044728","document":"tm2015378d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/tm2015378d2_4.xml","form_type":"4"}},{"id":3179938,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2020-04-08T21:53:45.000Z","date":"2020-04-06","kind":"tax_withholding","acquired":false,"shares":337,"price":43.22,"value":14565.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, which was previously reported."}],"balance_after":60893,"source":{"system":"sec-edgar","filing":"0001104659-20-044728","document":"tm2015378d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/tm2015378d2_4.xml","form_type":"4"}},{"id":3519068,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-05-20T20:32:16.000Z","date":"2019-05-17","kind":"sale","acquired":false,"shares":8907,"price":70.67,"value":629457.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $70.50 to $71.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61230,"source":{"system":"sec-edgar","filing":"0001144204-19-027313","document":"tv522071_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/tv522071_form4.xml","form_type":"4"}},{"id":3526399,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-05-15T20:32:15.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":4917,"price":70.31,"value":345714.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $70.00 to $70.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":70137,"source":{"system":"sec-edgar","filing":"0001144204-19-026614","document":"tv521699_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/tv521699_form4.xml","form_type":"4"}},{"id":3552967,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-04-18T20:33:27.000Z","date":"2019-04-16","kind":"tax_withholding","acquired":false,"shares":115,"price":68.6,"value":7889.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 375 shares of restricted stock, which was previously reported."}],"balance_after":75054,"source":{"system":"sec-edgar","filing":"0001144204-19-020281","document":"tv519118_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419020281/tv519118_form4.xml","form_type":"4"}},{"id":3559572,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-04-09T20:45:18.000Z","date":"2019-04-07","kind":"tax_withholding","acquired":false,"shares":144,"price":70.5,"value":10152.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 469 shares of restricted stock, which was previously reported."}],"balance_after":75169,"source":{"system":"sec-edgar","filing":"0001144204-19-018901","document":"tv518454_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/tv518454_form4.xml","form_type":"4"}},{"id":3559571,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-04-09T20:45:18.000Z","date":"2019-04-06","kind":"tax_withholding","acquired":false,"shares":337,"price":70.5,"value":23758.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, which was previously reported."}],"balance_after":75313,"source":{"system":"sec-edgar","filing":"0001144204-19-018901","document":"tv518454_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/tv518454_form4.xml","form_type":"4"}},{"id":3569686,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-04-02T20:46:59.000Z","date":"2019-03-31","kind":"tax_withholding","acquired":false,"shares":278,"price":70.54,"value":19610.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 906 shares of restricted stock, which was previously reported."}],"balance_after":75650,"source":{"system":"sec-edgar","filing":"0001144204-19-017770","document":"tv517845_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017770/tv517845_4.xml","form_type":"4"}},{"id":3572731,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Stock Options","published_at":"2019-04-01T20:02:15.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":8285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of March 28, 2019."}],"balance_after":8285,"derivative":{"exercise_price":66.39,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":8285},"source":{"system":"sec-edgar","filing":"0001144204-19-017412","document":"tv517661_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/tv517661_4.xml","form_type":"4"}},{"id":3572730,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2019-04-01T20:02:15.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":6848,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75928,"source":{"system":"sec-edgar","filing":"0001144204-19-017412","document":"tv517661_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/tv517661_4.xml","form_type":"4"}},{"id":3919106,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-05-24T20:01:47.000Z","date":"2018-05-22","kind":"tax_withholding","acquired":false,"shares":253,"price":61.88,"value":15655.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported."}],"balance_after":69080,"source":{"system":"sec-edgar","filing":"0001144204-18-030785","document":"tv494956_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418030785/tv494956_form4.xml","form_type":"4"}},{"id":3961360,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-04-18T20:34:03.000Z","date":"2018-04-16","kind":"tax_withholding","acquired":false,"shares":115,"price":60.21,"value":6924.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported."}],"balance_after":69333,"source":{"system":"sec-edgar","filing":"0001144204-18-021175","document":"tv491302_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418021175/tv491302_4.xml","form_type":"4"}},{"id":3966383,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Stock Options","published_at":"2018-04-10T21:26:29.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date."}],"balance_after":5300,"derivative":{"exercise_price":57.06,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001144204-18-019988","document":"tv490745_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418019988/tv490745_4.xml","form_type":"4"}},{"id":3966382,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-04-10T21:26:29.000Z","date":"2018-04-07","kind":"tax_withholding","acquired":false,"shares":144,"price":57.06,"value":8216.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported."}],"balance_after":69448,"source":{"system":"sec-edgar","filing":"0001144204-18-019988","document":"tv490745_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418019988/tv490745_4.xml","form_type":"4"}},{"id":3966381,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-04-10T21:26:29.000Z","date":"2018-04-06","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date."}],"balance_after":69592,"source":{"system":"sec-edgar","filing":"0001144204-18-019988","document":"tv490745_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418019988/tv490745_4.xml","form_type":"4"}},{"id":3974180,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-04-03T21:14:42.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":278,"price":58.22,"value":16185.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported."}],"balance_after":65192,"source":{"system":"sec-edgar","filing":"0001144204-18-018996","document":"tv490180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418018996/tv490180_form4.xml","form_type":"4"}},{"id":4008824,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Stock Options","published_at":"2018-03-07T22:00:56.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":3208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was April 1, 2014."}],"balance_after":1667,"derivative":{"exercise_price":33,"expiration_date":"2023-07-11","underlying":"Common Stock","underlying_shares":3208},"source":{"system":"sec-edgar","filing":"0001144204-18-013389","document":"tv487936_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418013389/tv487936_4.xml","form_type":"4"}},{"id":4008823,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Stock Options","published_at":"2018-03-07T22:00:56.000Z","date":"2018-03-05","kind":"exercise","acquired":false,"shares":14793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was July 12, 2013."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":14793},"source":{"system":"sec-edgar","filing":"0001144204-18-013389","document":"tv487936_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418013389/tv487936_4.xml","form_type":"4"}},{"id":4008822,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-03-07T22:00:56.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":4177,"price":61.92,"value":258639.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $62.80 to $63.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":65470,"source":{"system":"sec-edgar","filing":"0001144204-18-013389","document":"tv487936_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418013389/tv487936_4.xml","form_type":"4"}},{"id":4008821,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-03-07T22:00:56.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":3208,"price":33,"value":105864.0,"ownership":{"direct":true},"balance_after":69647,"source":{"system":"sec-edgar","filing":"0001144204-18-013389","document":"tv487936_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418013389/tv487936_4.xml","form_type":"4"}},{"id":4008820,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2018-03-07T22:00:56.000Z","date":"2018-03-05","kind":"exercise","acquired":true,"shares":14793,"price":6.36,"value":94083.48,"ownership":{"direct":true},"balance_after":66439,"source":{"system":"sec-edgar","filing":"0001144204-18-013389","document":"tv487936_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418013389/tv487936_4.xml","form_type":"4"}},{"id":4306870,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2017-05-24T20:30:55.000Z","date":"2017-05-22","kind":"tax_withholding","acquired":false,"shares":278,"price":47.01,"value":13068.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date."}],"balance_after":51549,"source":{"system":"sec-edgar","filing":"0001144204-17-029344","document":"v467760_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417029344/v467760_form4.xml","form_type":"4"}},{"id":4362421,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Stock Options","published_at":"2017-04-04T22:03:35.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date."}],"balance_after":7250,"derivative":{"exercise_price":49.51,"exercise_date":"2017-03-31","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001144204-17-018955","document":"v463546_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018955/v463546_form4.xml","form_type":"4"}},{"id":4362420,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":90074,"kind":"person","name":"Marken James G.","position":1,"cik":"0001579587","reported_name":"Marken James G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Ops & Prod Dev"}}],"security":"Common Stock","published_at":"2017-04-04T22:03:35.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":3625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date."}],"balance_after":51827,"source":{"system":"sec-edgar","filing":"0001144204-17-018955","document":"v463546_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018955/v463546_form4.xml","form_type":"4"}}]}